Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
Teva Pharmaceutical Industries Limited
Index- P/E307.64 EPS (ttm)0.11 Insider Own2.70% Shs Outstand981.66M Perf Week5.47%
Market Cap32.01B Forward P/E6.91 EPS next Y4.72 Insider Trans0.00% Shs Float912.42M Perf Month12.53%
Income78.00M PEG108.63 EPS next Q1.13 Inst Own59.10% Short Float3.34% Perf Quarter-0.46%
Sales22.72B P/S1.41 EPS this Y-96.10% Inst Trans-5.31% Short Ratio4.04 Perf Half Y-10.34%
Book/sh29.92 P/B1.09 EPS next Y-1.28% ROA0.10% Target Price36.83 Perf Year-36.52%
Cash/sh0.93 P/C35.10 EPS next 5Y2.83% ROE0.30% 52W Range27.59 - 56.44 Perf YTD-10.04%
Dividend1.36 P/FCF15.65 EPS past 5Y-53.00% ROI1.10% 52W High-42.22% Beta0.49
Dividend %4.17% Quick Ratio0.60 Sales past 5Y3.60% Gross Margin52.30% 52W Low18.17% ATR0.84
Employees56960 Current Ratio0.90 Sales Q/Q17.00% Oper. Margin8.30% RSI (14)69.73 Volatility2.39% 2.68%
OptionableYes Debt/Eq1.14 EPS Q/Q-8.00% Profit Margin0.30% Rel Volume0.74 Prev Close32.52
ShortableYes LT Debt/Eq1.08 EarningsMay 11 BMO Payout- Avg Volume7.55M Price32.61
Recom2.50 SMA209.35% SMA506.71% SMA200-10.55% Volume5,603,464 Change0.28%
Jun-16-17Upgrade Mizuho Neutral → Buy $25 → $30
Jun-16-17Initiated Cantor Fitzgerald Neutral $31
Feb-28-17Downgrade Argus Buy → Hold
Feb-13-17Reiterated Maxim Group Hold $41 → $40
Feb-10-17Downgrade Mizuho Buy → Neutral $40 → $27
Jan-31-17Upgrade BofA/Merrill Neutral → Buy
Jan-31-17Reiterated Barclays Equal Weight $46 → $38
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-09-17Downgrade Wells Fargo Outperform → Market Perform
Jan-06-17Downgrade Maxim Group Buy → Hold $49 → $41
Jan-03-17Reiterated Maxim Group Buy $52 → $49
Dec-07-16Resumed Oppenheimer Outperform
Nov-16-16Reiterated RBC Capital Mkts Outperform $58 → $51
Nov-16-16Reiterated Mizuho Neutral $45 → $40
Nov-16-16Reiterated Maxim Group Buy $72 → $52
Nov-16-16Reiterated Deutsche Bank Buy $68 → $54
Nov-16-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-16-16Downgrade Jefferies Buy → Hold $69 → $40
Nov-14-16Resumed Barclays Equal Weight $46
Nov-14-16Reiterated RBC Capital Mkts Outperform $71 → $58
Jun-25-17 09:42AM  These 3 Stocks Are Up Over 500% in the Last 3 Years Motley Fool
Jun-24-17 10:01AM  Facebook, Baidu, Coach And 5 Other Blue-Chip Stocks To Buy For Second-Half 2017 Forbes
Jun-23-17 08:00AM  Today's Research Reports on Stocks to Watch: Geron Corporation and Teva Pharmaceutical Accesswire
Jun-22-17 10:06AM  Glaxo's (GSK) Shingles Candidate Phase III Data Positive Zacks
Jun-21-17 06:41PM  GSK wins $235 million from Teva in Coreg patent trial Reuters
07:25AM  Israeli credit card firm Isracard names outgoing Teva CFO as chairman Reuters
Jun-20-17 03:18PM  ETFs with exposure to Teva Pharmaceutical Industries Ltd. : June 20, 2017 Capital Cube
02:06PM  Dupixent May Prove Effective in Multiple Diseases Market Realist
12:20PM  Label Expansion May Boost Regenerons Dupixent in the Future Market Realist
08:04AM  Should Investors Steer Clear of Opioid Drug Stocks? Motley Fool
Jun-19-17 01:47PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Isnt Healed by Paulsons Presence InvestorPlace
11:52AM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Time to Go Contrarian? InvestorPlace
11:47AM  Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
Jun-16-17 09:33AM  Teva Pharmaceuticals Upgraded at Mizuho
08:07AM  3 Dividend Stocks in Healthcare Motley Fool
Jun-15-17 12:54PM  Biotech Stocks To Watch And Pharma Industry News Investor's Business Daily
Jun-14-17 08:58PM  States Launch Bipartisan Probe of Opioid Marketing and Addiction The Wall Street Journal
Jun-13-17 12:07PM  Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space
08:00AM  Today's Research Reports on Stocks to Watch: Celgene and Teva Pharmaceutical Industries Accesswire
07:55AM  Teva launches generic version of Merck cholesterol-lowering medicine American City Business Journals
01:08AM  [$$] Nassau County Sues Drugmakers Over Opioid Epidemic The Wall Street Journal
Jun-12-17 07:18PM  [$$] Nassau County Sues Drugmakers Over Opioid Epidemic The Wall Street Journal
03:16PM  Teva Announces Launch of Generic Zetia® in the United States Business Wire
08:55AM  Short Sellers Grow More Selective on Major Pharma 24/7 Wall St.
Jun-11-17 02:27PM  Opioid Stocks Feel the Pressure of FDA Measures Investopedia
03:52AM  Teva Pharm looks to refresh board with four new nominees Reuters
Jun-09-17 01:43PM  Pharmaceutical Stocks Gain on Promising Migraine Drugs with Hefty Price Tags
09:30AM  Teva Pharmaceutical Stock Rising on Generic Eye Drop Launch
08:53AM  Teva Announces Exclusive Launch of Generic Pataday® in the United States Business Wire
01:21AM  [$$] Teva Pharmaceutical to Nominate Four New Directors The Wall Street Journal
Jun-08-17 04:03PM  [$$] Teva Pharmaceutical to Nominate Four New Directors The Wall Street Journal
10:06AM  Teva Migraine Candidate Succeeds in Second Phase III Study Zacks
04:28AM  Teva Signals It's Seeking New Chief With Experience at Helm Bloomberg
Jun-07-17 05:47PM  People Shouldn't Be Surprised by Mylan's Desperate Attempt to Distort the Facts, Says Official
10:38AM  Teva's migraine drug clears another hurdle, aims for launch in 2018 Reuters
08:00AM  Teva's Fremanezumab Meets all Primary & Secondary Endpoints Across Both Monthly and Quarterly Dosing Regimens in Phase III Study in Episodic Migraine Prevention Business Wire
Jun-06-17 01:55PM  3 Reasons Teva Pharmaceutical Industries Ltd. Nosedived 12% in May Motley Fool
08:00AM  Teva to Present at the Jefferies 2017 Global Healthcare Conference Business Wire
Jun-05-17 12:40PM  Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : June 05th, 2017 (record date) : By the numbers : June 5, 2017 Capital Cube
Jun-02-17 08:12AM  Pharma Stock Roundup: Positive Data from Lilly & Teva, BMY's Deals & More Zacks
Jun-01-17 08:00AM  Teva to Present Data from 18 Abstracts in Tardive Dyskinesia and Huntington Disease at the 21st International Congress of Parkinsons Disease and Movement Disorders Business Wire
May-31-17 04:25PM  Teva Pharma Ran A Migraine Trial And Lilly, Amgen Benefited Investor's Business Daily
02:43PM  [$$] Ohio sues drugmakers over US opioid addiction crisis Financial Times
12:10PM  Johnson and Johnson, other drug companies accused of viol... CNBC Videos
10:08AM  5 Drug Stocks in Focus on World MS Day Zacks
08:48AM  Investment funds urge shareholders to vote down Mylan board, pay Reuters
08:22AM  Teva Announces Positive Results for Phase III Study of Fremanezumab for the Prevention of Chronic Migraine Business Wire
May-30-17 12:13PM  Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1 Investopedia
May-26-17 03:02PM  3 Top Dividend Stocks in Generic Drugs Motley Fool
May-25-17 04:10PM  Teva Pharma, Eagle Pharma, Depomed Among Slew Getting Price Haircuts Investor's Business Daily
04:04PM  How Teva Is Fighting (and Losing) the Big Pharma Battle Investopedia
09:45AM  Major Pharma Short Interest Surges 24/7 Wall St.
May-24-17 07:00PM  Cramer Remix: The market is not ready for this Trump scen... CNBC Videos
04:21PM  Did Neurocrine Just Leave The Door Open For Teva In Tourette's? Investor's Business Daily
10:37AM  Neupogen and Enbrel Could See Falling Revenues in 2017 Market Realist
08:00AM  Today's Research Reports on Stocks to Watch: Teva and Cerus Corporation Accesswire
May-23-17 04:23PM  Teva Reaches New Lows Will It Bottom Out? Investopedia
May-22-17 12:25PM  It's Easy To Be Skeptical Of Mylan, But Don't Ignore This Pending PDUFA Date Benzinga
08:27AM  3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter Motley Fool
May-19-17 01:33PM  Valeant Pharmaceuticals: IntriguedReally?
09:48AM  Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA Zacks
07:30AM  Vetr Issues Strong Buy As Teva Trends Down Benzinga
May-18-17 09:53AM  Teva Pharmaceutical Leaning Towards Foreigner as New CEO
07:42AM  Teva Pharmaceutical's search committee recommends foreign CEO: report Reuters
07:37AM  Teva Pharmaceutical's search committee recommends foreign CEO -report Reuters
May-17-17 09:00AM  Teva Showcases Asthma Research at the 2017 American Thoracic Society (ATS) International Conference Business Wire
08:00AM  Teva to Present Data for Deutetrabenazine in Tardive Dyskinesia at the American Psychiatric Association 2017 Annual Meeting Business Wire
May-16-17 09:54AM  Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka Zacks
May-15-17 07:06PM  Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint Zacks
05:59PM  John Paulson Takes A Shine To Telecom The Wall Street Journal
01:20PM  Teva Announces Launch of Generic Glumetza® in the United States Business Wire
08:00AM  Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125) Business Wire
07:09AM  Biostime International Holdings Limited -- Moody's: Biostime's ratings unaffected by disclosure of PGT option in collaboration agreement with Swisse Moody's
May-12-17 04:20PM  Can Teva Hold Its Own In Bringing Migraine Drugs To Market? Investor's Business Daily
10:26AM  Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets Motley Fool
08:00AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceuticals and Merck & Co. Accesswire
07:34AM  Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls Zacks
12:19AM  [$$] Investors Are Losing Patience With Teva The Wall Street Journal
May-11-17 04:17PM  [$$] Investors Are Losing Patience With Teva The Wall Street Journal
04:04PM  Teva Pharma Q1 Sales Lag As Key Multiple Sclerosis Drug Topples Investor's Business Daily
02:30PM  TEVA's Every Narrowing Margin for Error Investopedia
12:07PM  Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers
11:43AM  Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher Motley Fool
11:27AM  Market Overly Negative on Teva Morningstar
09:46AM  Teva Q1 profit tops estimates, revenue up on Actavis deal Reuters
08:39AM  Teva (TEVA) Q1 Earnings In-Line, Sales Miss, Shares Up Zacks
07:54AM  Early movers: STRP, SNAP, FOXA, WFM, KSS, TEVA, YUM & more CNBC
07:30AM  Teva to Sell Assets Such as Women's Health Unit to Cut Debt Bloomberg
07:23AM  Market Recon: Snapchat Is Down Sharply; Yet, I Am Not Tempted
07:17AM  Teva stock rises 1.6% after Q1 profit beat, revenue miss MarketWatch
07:16AM  Teva Pharm Q1 profit tops estimates, revenue rises Reuters
07:00AM  Teva Reports First Quarter 2017 Financial Results Business Wire
May-10-17 04:52PM  4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning Motley Fool
09:00AM  Short Interest in Major Pharma Shrinks 24/7 Wall St.
May-09-17 02:22PM  Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings? Zacks
May-08-17 09:26AM  Teva Pharmaceutical (TEVA) Q1 Earnings: What's in the Cards? Zacks
May-05-17 02:00PM  Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint Business Wire
08:00AM  Teva Announces Publication of COPAXONE® (glatiramer acetate injection) Pregnancy Data in the International Journal of MS Care Business Wire
07:00AM  Generic Drug Industry Headwinds Lead to Moat Downgrades Morningstar
May-04-17 08:23AM  Generic Drugmakers Tumble as Perrigo Discloses DoJ Search Zacks
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson's disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women's health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.